Literature DB >> 21106230

Procoagulant activity, but not number, of microparticles increases with age and in individuals after a single venous thromboembolism.

B A L Owen1, A Xue, J A Heit, W G Owen.   

Abstract

The Calibrated Automated Thrombogram (CAT), a plate-based assay that measures thrombin generation and inhibition in plasma samples, is modified to measure the procoagulant activity of phospholipid associated with plasma microparticles (MP). The assay uses a tissue factor trigger without addition of 4 μM exogenous phospholipid (PL) used in the standard CAT. Calibrated with 4:1 posphatidylcholine- phosphatidylserine (PCPS) liposomes, the assay defines a median of 40 nM procoagulant phospholipid (PPL) equivalents in plasma containing MPs from 50 normal donors, with a range from 20 - 200 nM. Like the standard CAT, the modified assay detected no difference in plasma from 36 individuals with a history of a single episode of venous thromboembolism. However the male cases had double the PPL activity, as measured by rate of thrombin generation, of females; and there was a significant correlation among cases of increased thrombin generation with age. In contrast, there were no gender disparities or age correlations among control plasmas. The findings suggest that procoagulant activity of plasma microparticles, facilitated by a simplified, one-stage plate-based assay, offer a promising avenue of investigation of mechanisms and management of venous thromboembolic disorders.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21106230      PMCID: PMC3076027          DOI: 10.1016/j.thromres.2010.10.018

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  47 in total

1.  Circulating procoagulant microparticles in patients with venous thromboembolism.

Authors:  Cihan Ay; Jean-Marie Freyssinet; Thomas Sailer; Rainer Vormittag; Ingrid Pabinger
Journal:  Thromb Res       Date:  2008-11-07       Impact factor: 3.944

Review 2.  Thrombin generation assays: accruing clinical relevance.

Authors:  H Coenraad Hemker; Raed Al Dieri; Suzette Béguin
Journal:  Curr Opin Hematol       Date:  2004-05       Impact factor: 3.284

3.  Thrombotic risk assessment in the antiphospholipid syndrome requires more than the quantification of lupus anticoagulants.

Authors:  Katrien Devreese; Kathelijne Peerlinck; Marc F Hoylaerts
Journal:  Blood       Date:  2009-11-25       Impact factor: 22.113

4.  High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study.

Authors:  M Besser; C Baglin; R Luddington; A van Hylckama Vlieg; T Baglin
Journal:  J Thromb Haemost       Date:  2008-08-01       Impact factor: 5.824

Review 5.  Duration of anticoagulation after initial idiopathic venous thrombosis--the swinging pendulum: risk assessment to predict recurrence.

Authors:  S Eichinger; P A Kyrle
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

6.  High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism.

Authors:  A Tripodi; C Legnani; V Chantarangkul; B Cosmi; G Palareti; P M Mannucci
Journal:  J Thromb Haemost       Date:  2008-05-15       Impact factor: 5.824

7.  Prevention of the influence of fibrin and alpha2-macroglobulin in the continuous measurement of the thrombin potential: implications for an endpoint determination of the optical density.

Authors:  D T Rijkers; S J Wielders; S Béguin; H C Hemker
Journal:  Thromb Res       Date:  1998-02-15       Impact factor: 3.944

8.  Reactions of activated factor X-phosphatide mixtures in vitro and in vivo.

Authors:  P G Barton; E T Yin; S Wessler
Journal:  J Lipid Res       Date:  1970-03       Impact factor: 5.922

9.  Atherogenic, hemostatic, and other potential risk markers in subjects with previous isolated myocardial infarction compared with long-standing uncomplicated stable angina.

Authors:  P Bogaty; N M Robitaille; S Solymoss; L Boyer; D Auger; L Labbé; S Simard; J Rail; J Genest; J Turgeon
Journal:  Am Heart J       Date:  1998-11       Impact factor: 4.749

10.  Towards a standardization of thrombin generation assessment: the influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram-Thrombinoscope assay.

Authors:  Grigoris T Gerotziafas; François Depasse; Joël Busson; Lena Leflem; Ismail Elalamy; Meyer M Samama
Journal:  Thromb J       Date:  2005-10-26
View more
  10 in total

1.  Methodology for isolation, identification and characterization of microvesicles in peripheral blood.

Authors:  Muthuvel Jayachandran; Virginia M Miller; John A Heit; Whyte G Owen
Journal:  J Immunol Methods       Date:  2011-10-29       Impact factor: 2.303

2.  Quantification of hypercoagulable state after blunt trauma: microparticle and thrombin generation are increased relative to injury severity, while standard markers are not.

Authors:  Myung S Park; Barbara A L Owen; Beth A Ballinger; Michael G Sarr; Henry J Schiller; Scott P Zietlow; Donald H Jenkins; Mark H Ereth; Whyte G Owen; John A Heit
Journal:  Surgery       Date:  2012-02-07       Impact factor: 3.982

3.  Microparticles formed during storage of red blood cell units support thrombin generation.

Authors:  Beth A Bouchard; Thomas Orfeo; Hollis N Keith; Elizabeth M Lavoie; Matthew Gissel; Mark Fung; Kenneth G Mann
Journal:  J Trauma Acute Care Surg       Date:  2018-04       Impact factor: 3.313

4.  Thrombin generation profiles as predictors of symptomatic venous thromboembolism after trauma: A prospective cohort study.

Authors:  Myung S Park; Grant M Spears; Kent R Bailey; Ailing Xue; Michael J Ferrara; Amy Headlee; Sabtir K Dhillon; Donald H Jenkins; Scott P Zietlow; William S Harmsen; Aneel A Ashrani; John A Heit
Journal:  J Trauma Acute Care Surg       Date:  2017-09       Impact factor: 3.313

5.  Thrombin generation and procoagulant microparticle profiles after acute trauma: A prospective cohort study.

Authors:  Myung S Park; Ailing Xue; Grant M Spears; Timothy M Halling; Michael J Ferrara; Melissa M Kuntz; Sabtir K Dhillon; Donald H Jenkins; William S Harmsen; Karla V Ballman; Paul Harrison; John A Heit
Journal:  J Trauma Acute Care Surg       Date:  2015-11       Impact factor: 3.313

6.  Proteomic characteristics of circulating microparticles in patients with newly-diagnosed type 2 diabetes.

Authors:  Min-Dan Xu; Xian-Zheng Wu; Yun Zhou; Ying Xue; Ke-Qin Zhang
Journal:  Am J Transl Res       Date:  2016-01-15       Impact factor: 4.060

7.  Procoagulant and platelet-derived microvesicle absolute counts determined by flow cytometry correlates with a measurement of their functional capacity.

Authors:  Lisa Ayers; Paul Harrison; Malcolm Kohler; Berne Ferry
Journal:  J Extracell Vesicles       Date:  2014-09-30

8.  Plasma procoagulant phospholipid clotting time and venous thromboembolism risk.

Authors:  Cathrine Ramberg; Line Wilsgård; Nadezhda Latysheva; Sigrid K Brækkan; Kristian Hindberg; Timofey Sovershaev; Omri Snir; John-Bjarne Hansen
Journal:  Res Pract Thromb Haemost       Date:  2021-12-20

Review 9.  Tissue factor structure and function.

Authors:  Saulius Butenas
Journal:  Scientifica (Cairo)       Date:  2012-12-26

10.  Elevated Circulatory Levels of Microparticles Are Associated to Lung Fibrosis and Vasculopathy During Systemic Sclerosis.

Authors:  Damien Leleu; Emeline Levionnois; Paoline Laurent; Estibaliz Lazaro; Christophe Richez; Pierre Duffau; Patrick Blanco; Vanja Sisirak; Cecile Contin-Bordes; Marie-Elise Truchetet
Journal:  Front Immunol       Date:  2020-10-23       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.